Discover how GLP-1 drugs like semaglutide are revolutionizing kidney disease treatment, cutting risk by 24% in landmark trials. Join host Julia Cartwright as she uncovers the science, breakthrough research, and future of kidney protection for millions with chronic kidney disease. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.